De-Differentiation Confers Multidrug Resistance Via Noncanonical PERK-Nrf2 Signaling

Upregulation of PERK-Nrf2 signaling is a key mechanism by which de-differentiated cancer cells gain multi-drug resistance.

• Publication year

  2014

• Venue

  PLoS Biology

• Publication date

  2014-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1371/journal.pbio.1001945PMID 25203443PMCID 4159113
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Epithelial-to-mesenchymal transition activates PERK-eIF2α and sensitizes cells to endoplasmic reticulum stress.

  2014cited by this paper
• Intestinal tumorigenesis initiated by dedifferentiation and acquisition of stem-cell-like properties.

  2013cited by this paper
• Phosphorylation of p62 activates the Keap1-Nrf2 pathway during selective autophagy.

  2013cited by this paper
• Characterization of a novel PERK kinase inhibitor with antitumor and antiangiogenic activity.

  2013cited by this paper
• SOX2 promotes dedifferentiation and imparts stem cell-like features to pancreatic cancer cells

  2013cited by this paper
• Sub-Sets of Cancer Stem Cells Differ Intrinsically in Their Patterns of Oxygen Metabolism

  2013cited by this paper
• UPR-Induced Resistance to Etoposide Is Downstream of PERK and Independent of Changes in Topoisomerase IIα Levels

  2012cited by this paper
• Discovery of 7-methyl-5-(1-{[3-(trifluoromethyl)phenyl]acetyl}-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (GSK2606414), a potent and selective first-in-class inhibitor of protein kinase R (PKR)-like endoplasmic reticulum kinase (PERK).

  2012influential reference
• The unfolded protein response induces the angiogenic switch in human tumor cells through the PERK/ATF4 pathway.

  2012cited by this paper
• Histone Deacetylase Inhibitors Stimulate Dedifferentiation of Human Breast Cancer Cells Through WNT/β‐Catenin Signaling

  2012cited by this paper
• Paracrine and autocrine signals induce and maintain mesenchymal and stem cell states in the breast.

  2011cited by this paper
• Transcription factors that mediate epithelial–mesenchymal transition lead to multidrug resistance by upregulating ABC transporters

  2011cited by this paper
• Differentiation therapy: targeting human renal cancer stem cells with interleukin 15.

  2011cited by this paper
• Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells.

  2011cited by this paper
• Acute promyelocytic leukemia: a paradigm for differentiation therapy.

  2010cited by this paper
• Oncogenic NRF2 mutations in squamous cell carcinomas of oesophagus and skin

  2010cited by this paper
• Differentiation Therapy Exerts Antitumor Effects on Stem-like Glioma Cells

  2010cited by this paper
• Menadione triggers cell death through ROS-dependent mechanisms involving PARP activation without requiring apoptosis.

  2010cited by this paper
• EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer

  2010cited by this paper
• Global mapping of binding sites for Nrf2 identifies novel targets in cell survival response through ChIP-Seq profiling and network analysis

  2010cited by this paper
• Association of reactive oxygen species levels and radioresistance in cancer stem cells

  2009cited by this paper
• Glucose-regulated protein 78 antagonizes cisplatin and adriamycin in human melanoma cells.

  2009cited by this paper
• Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer.

  2009cited by this paper
• Twist1-Mediated Adriamycin-Induced Epithelial-Mesenchymal Transition Relates to Multidrug Resistance and Invasive Potential in Breast Cancer Cells

  2009cited by this paper
• The epithelial-mesenchymal transition generates cells with properties of stem cells.

  2008cited by this paper
• Nrf2 signaling: an adaptive response pathway for protection against environmental toxic insults.

  2008cited by this paper
• Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2.

  2008cited by this paper
• Generation of Breast Cancer Stem Cells through Epithelial-Mesenchymal Transition

  2008cited by this paper
• Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer.

  2008cited by this paper
• Epithelial mesenchymal transition traits in human breast cancer cell lines

  2008cited by this paper
• The transcription factor ZEB1 (δEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity

  2007cited by this paper
• The biology of cancer stem cells.

  2007cited by this paper
• Molecular heterogeneity of breast carcinomas and the cancer stem cell hypothesis

  2007cited by this paper
• Gene expression profiling of breast cell lines identifies potential new basal markers

  2006cited by this paper
• Dysfunctional KEAP1–NRF2 Interaction in Non-Small-Cell Lung Cancer

  2006cited by this paper
• UPR activation alters chemosensitivity of tumor cells

  2006cited by this paper
• Perk-Dependent Translational Regulation Promotes Tumor Cell Adaptation and Angiogenesis in Response to Hypoxic Stress

  2006cited by this paper
• ABC transporters as multidrug resistance mechanisms and the development of chemosensitizers for their reversal

  2005cited by this paper
• Activation of the Unfolded Protein Response Is Necessary and Sufficient for Reducing Topoisomerase IIα Protein Levels and Decreasing Sensitivity to Topoisomerase-Targeted Drugs

  2005cited by this paper
• Preclinical evaluation of the proteasome inhibitor bortezomib in cancer therapy

  2005cited by this paper
• Tumour stem cells and drug resistance

  2005cited by this paper
• Bioconductor: open software development for computational biology and bioinformatics

  2004cited by this paper
• Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis.

  2004cited by this paper
• Nrf2 Is a Direct PERK Substrate and Effector of PERK-Dependent Cell Survival

  2003cited by this paper
• Cisplatin Induces Endoplasmic Reticulum Stress and Nucleus-independent Apoptotic Signaling*

  2003cited by this paper
• Glucose depletion enhances P-glycoprotein expression in hepatoma cells: role of endoplasmic reticulum stress response.

  2003cited by this paper
• NF-κB transcription factor induces drug resistance through MDR1 expression in cancer cells

  2003cited by this paper
• Endoplasmic Reticulum Chaperone Protein GRP78 Protects Cells from Apoptosis Induced by Topoisomerase Inhibitors

  2003cited by this paper
• Molecular mechanisms of N-acetylcysteine actions

  2003cited by this paper
• Treatment of acute promyelocytic leukemia: strategy toward further increase of cure rate

  2003cited by this paper
• Epithelial–mesenchymal transitions in tumour progression

  2002cited by this paper
• Phosphorylation of Nrf2 at Ser-40 by Protein Kinase C Regulates Antioxidant Response Element-mediated Transcription*

  2002cited by this paper
• Phosphatidylinositol 3-Kinase, Not Extracellular Signal-regulated Kinase, Regulates Activation of the Antioxidant-Responsive Element in IMR-32 Human Neuroblastoma Cells*

  2001cited by this paper
• The Cap'n'Collar basic leucine zipper transcription factor Nrf2 (NF-E2 p45-related factor 2) controls both constitutive and inducible expression of intestinal detoxification and glutathione biosynthetic enzymes.

  2001cited by this paper
• Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice

  2001cited by this paper
• Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells.

  2001cited by this paper
• Reversal of Physiological Stress-Induced Resistance to Topoisomerase II Inhibitors Using an Inducible Phosphorylation Site-Deficient Mutant of I (cid:1) B (cid:2)

  2001cited by this paper
• Stem cells, cancer, and cancer stem cells

  2001cited by this paper
• Prostaglandin A1 inhibits stress-induced NF-kappaB activation and reverses resistance to topoisomerase II inhibitors.

  2001cited by this paper
• Reversal of physiological stress-induced resistance to topoisomerase II inhibitors using an inducible phosphorylation site-deficient mutant of I kappa B alpha.

  2001cited by this paper
• Mechanism of heme oxygenase-1 gene activation by cadmium in MCF-7 mammary epithelial cells. Role of p38 kinase and Nrf2 transcription factor.

  2000cited by this paper
• Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase

  1999cited by this paper
• Nrf2, a Cap’n’Collar Transcription Factor, Regulates Induction of the Heme Oxygenase-1 Gene*

  1999cited by this paper
• An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements.

  1997cited by this paper
• Hypersensitivity to DNA cross-linking agents associated with up-regulation of glucose-regulated stress protein GRP78.

  1997cited by this paper
• Cell biological mechanisms of multidrug resistance in tumors.

  1994cited by this paper
• How cancer cells evade chemotherapy: sixteenth Richard and Hinda Rosenthal Foundation Award Lecture.

  1993cited by this paper
• Resistance to etoposide induced by three glucose-regulated stresses in Chinese hamster ovary cells.

  1989cited by this paper
• Heme oxygenase: function, multiplicity, regulatory mechanisms, and clinical applications

  1988cited by this paper
• Coinduction of glucose-regulated proteins and doxorubicin resistance in Chinese hamster cells.

  1987cited by this paper
• Identification and Characterization of Pancreatic Eukaryotic Initiation Factor 2 a -Subunit Kinase, PEK, Involved in Translational Control

  year unknowncited by this paper

• Cancer Cell Dormancy and Chemotherapy Resistance

  2026cites this paper
• PERK-dependent reciprocal crosstalk between ER and non-centrosomal microtubules coordinates ER architecture and cell shape

  2025cites this paper
• ER stress and/or ER-phagy in drug resistance? Three coincidences are proof

  2025cites this paper
• Endoplasmic Reticulum Stress and Its Role in Metabolic Reprogramming of Cancer

  2025cites this paper
• EMT-ciliary signaling in quasi-mesenchymal-stem-like cells drives therapeutic resistance and is a druggable vulnerability in triple-negative breast cancer

  2025cites this paper
• Targeting the PERK/NRF2 Pathway: Enhancing cisplatin Efficacy in Resistant Ovarian Cancer Cells through MRP1 and ROS Modulation.

  2025cites this paper
• Endoplasmic Reticulum Stress: Triggers Microenvironmental Regulation and Drives Tumor Evolution

  2025cites this paper
• NCI 159456 PERK Inhibitor as a Targeted Therapy for Lung Cancer: An In Vitro Study

  2024cites this paper
• Targeting the key players of phenotypic plasticity in cancer cells by phytochemicals

  2024cites this paper
• Emerging mechanisms of the unfolded protein response in therapeutic resistance: from chemotherapy to Immunotherapy

  2024cites this paper
• Breast cancer stem cells origins and the memory stem cells: clinical significance of biomarkers and the active therapeutic approaches

  2024cites this paper
• Homeostasis control in health and disease by the unfolded protein response

  2024cites this paper
• The UPRising connection between endoplasmic reticulum stress and the tumor microenvironment.

  2024cites this paper
• Activation of the PERK/eIF2α axis is a pivotal prerequisite of taxanes to cancer cell apoptosis and renders synergism to overcome paclitaxel resistance in breast cancer cells

  2024cites this paper
• The unfolded protein response machinery in glioblastoma genesis, chemoresistance and as a druggable target

  2024cites this paper
• Endoplasmic reticulum stress and quality control in relation to cisplatin resistance in tumor cells

  2024cites this paper
• How to deal with frenemy NRF2: Targeting NRF2 for chemoprevention and cancer therapy

  2023cites this paper
• The Multi-Faceted Consequences of NRF2 Activation throughout Carcinogenesis

  2023cites this paper
• Emerging Role of NRF2 Signaling in Cancer Stem Cell Phenotype

  2023cites this paper
• The clinical relevance of unfolded protein response signaling in breast cancer.

  2022cites this paper
• Understanding ER homeostasis and the UPR to enhance treatment efficacy of acute myeloid leukemia.

  2022cites this paper
• CFTR reduces the proliferation of lung adenocarcinoma and is a strong predictor of survival in both smokers and non-smokers

  2022cites this paper
• The Role of Endoplasmic Reticulum and Mitochondria in Maintaining Redox Status and Glycolytic Metabolism in Pluripotent Stem Cells

  2022cites this paper
• Role of Nrf2 Signaling Cascade in Breast Cancer: Strategies and Treatment

  2022cites this paper
• The unfolded protein response (UPR) pathway: the unsung hero in breast cancer management

  2022cites this paper
• Drug and apoptosis resistance in cancer stem cells: a puzzle with many pieces

  2022cites this paper
• Endoplasmic Reticulum Stress and Tumor Microenvironment in Bladder Cancer: The Missing Link

  2021cites this paper
• Paradoxical effects of DNA tumor virus oncogenes on epithelium-derived tumor cell fate during tumor progression and chemotherapy response

  2021cites this paper
• Transcriptional Control of Metastasis by Integrated Stress Response Signaling

  2021cites this paper
• Targeting UPR branches, a potential strategy for enhancing efficacy of cancer chemotherapy.

  2021cites this paper
• GRP78 Overexpression Triggers PINK1-IP3R-Mediated Neuroprotective Mitophagy

  2021cites this paper
• PERK mediates resistance to BRAF inhibition in melanoma with impaired PTEN

  2021cites this paper
• Involvement of NRF2 in Breast Cancer and Possible Therapeutical Role of Polyphenols and Melatonin

  2021cites this paper
• Regulation of Nrf2 by phosphorylation: consequences for biological function and therapeutic implications.

  2021cites this paper
• Structural and Functional Significance of the Endoplasmic Reticulum Unfolded Protein Response Transducers and Chaperones at the Mitochondria–ER Contacts: A Cancer Perspective

  2021cites this paper
• The multifaceted role of NRF2 in cancer progression and cancer stem cells maintenance

  2021cites this paper
• Unraveling the Molecular Nexus between GPCRs, ERS, and EMT

  2021cites this paper
• PERK-dependent reciprocal crosstalk between ER and non-centrosomal microtubules coordinates ER architecture and cell shape

  2021cites this paper
• The innate immune effector ISG12a promotes cancer immunity by suppressing the canonical Wnt/β-catenin signaling pathway

  2020cites this paper
• Deschampsia antarctica extract (Edafence®) as a powerful skin protection tool against the aging exposome

  2020cites this paper
• Targeting the Unfolded Protein Response in Hormone-Regulated Cancers.

  2020cites this paper
• Plasticity of Cancer Stem Cell: Origin and Role in Disease Progression and Therapy Resistance

  2020cites this paper
• SOX2OT Long Noncoding RNA Is Regulated by the UPR in Oestrogen Receptor-Positive Breast Cancer

  2020cites this paper
• The Intimate Relationship among EMT, MET and TME: A T(ransdifferentiation) E(nhancing) M(ix) to Be Exploited for Therapeutic Purposes

  2020cites this paper
• Targeting ferroptosis in breast cancer

  2020cites this paper
• Gain-of-function genetic screen of the kinome reveals BRSK2 as an inhibitor of the NRF2 transcription factor

  2020cites this paper
• Counteracting Chemoresistance with Metformin in Breast Cancers: Targeting Cancer Stem Cells

  2020cites this paper
• Role of Nrf2 and mitochondria in cancer stem cells; in carcinogenesis, tumor progression, and chemoresistance.

  2020cites this paper
• Chemotherapy Resistance Explained through Endoplasmic Reticulum Stress-Dependent Signaling

  2019cites this paper
• Phenotypic Plasticity: Driver of Cancer Initiation, Progression, and Therapy Resistance.

  2019influential citation
• Activation of the PERK-ATF4 pathway promotes chemo-resistance in colon cancer cells

  2019cites this paper
• PERK regulates Nrf2/ARE antioxidant pathway against dibutyl phthalate-induced mitochondrial damage and apoptosis dependent of reactive oxygen species in mouse spermatocyte-derived cells.

  2019cites this paper
• Cancer Stem Cells, Apoptosis Pathways and Mechanisms of Death Resistance

  2019cites this paper
• UPR: An Upstream Signal to EMT Induction in Cancer

  2019cites this paper
• Contribution of Epithelial Plasticity to Therapy Resistance

  2019cites this paper
• A sensitive and simple targeted proteomics approach to quantify transcription factor and membrane proteins of the unfolded protein response pathway in glioblastoma cells

  2019cites this paper
• Dual role of Endoplasmic Reticulum Stress-Mediated Unfolded Protein Response Signaling Pathway in Carcinogenesis

  2019cites this paper
• The Emerging Roles of Cancer Stem Cells and Wnt/Beta-Catenin Signaling in Hepatoblastoma

  2019cites this paper
• Breast Cancer Stem Cells as Drivers of Tumor Chemoresistance, Dormancy and Relapse: New Challenges and Therapeutic Opportunities

  2019cites this paper
• Redox-Mediated Mechanism of Chemoresistance in Cancer Cells

  2019cites this paper
• Proteostasis in the Endoplasmic Reticulum: Road to Cure

  2019cites this paper
• Regulation of autophagy by canonical and non-canonical ER stress responses.

  2019cites this paper
• HIV-1 Reverse Transcriptase Promotes Tumor Growth and Metastasis Formation via ROS-Dependent Upregulation of Twist

  2019cites this paper
• Gain-of-function genetic screen of the kinome reveals BRSK2 as an inhibitor of the NRF2 transcription factor

  2019cites this paper
• Resistance to drugs and cell death in cancer stem cells (CSCs)

  2019cites this paper
• Type I interferons and endoplasmic reticulum stress in health and disease

  2019cites this paper
• Coordinating Organismal Physiology Through the Unfolded Protein Response

  2018cites this paper
• Contribution of the unfolded protein response to breast and prostate tissue homeostasis and its significance to cancer endocrine response

  2018cites this paper
• Metformin reverses the resistance mechanism of lung adenocarcinoma cells that knocks down the Nrf2 gene.

  2018cites this paper
• Protein Quality Control in the Endoplasmic Reticulum and Cancer

  2018cites this paper
• The Unfolded Protein Response in Breast Cancer

  2018cites this paper
• Nrf2/P-glycoprotein axis is associated with clinicopathological characteristics in colorectal cancer.

  2018cites this paper
• ROS-independent ER stress-mediated NRF2 activation promotes warburg effect to maintain stemness-associated properties of cancer-initiating cells

  2018cites this paper
• Homeostatic interplay between FoxO proteins and ER proteostasis in cancer and other diseases.

  2018cites this paper
• Driving Cancer Tumorigenesis and Metastasis Through UPR Signaling.

  2018cites this paper
• Endoplasmic reticulum stress signaling and chemotherapy resistance in solid cancers

  2017cites this paper
• Gastrin induces multidrug resistance via the degradation of p27Kip1 in the gastric carcinoma cell line SGC7901.

  2017cites this paper
• Mechanisms of β-cell dedifferentiation in diabetes: recent findings and future research directions.

  2017cites this paper
• SETD7 is a prognosis predicting factor of breast cancer and regulates redox homeostasis

  2017cites this paper
• Unfolded Protein Response of the Endoplasmic Reticulum in Tumor Progression and Immunogenicity

  2017cites this paper
• NRF2 Is a Potential Modulator of Hyperresistance to Arsenic Toxicity in Stem-Like Keratinocytes

  2017cites this paper
• Rifampicin-induced injury in HepG2 cells is alleviated by TUDCA via increasing bile acid transporters expression and enhancing the Nrf2-mediated adaptive response.

  2017cites this paper
• Strange Bedfellows: Nuclear Factor, Erythroid 2-Like 2 (Nrf2) and Hypoxia-Inducible Factor 1 (HIF-1) in Tumor Hypoxia

  2017cites this paper
• Reactive Oxygen Species-Mediated Autophagy Defines the Fate of Cancer Stem Cells

  2017cites this paper
• Activation of the unfolded protein response promotes axonal regeneration after peripheral nerve injury

  2016cites this paper
• Signaling the Unfolded Protein Response in primary brain cancers.

  2016cites this paper
• PERK Integrates Oncogenic Signaling and Cell Survival During Cancer Development

  2016cites this paper
• Resistencias al tratamiento no quirúrgico en cáncer cutáneo no melanoma. Parte II: terapia fotodinámica, vismodegib, cetuximab, metotrexato intralesional y radioterapia

  2016cites this paper
• Reprint of: Signaling the Unfolded Protein Response in primary brain cancers

  2016cites this paper
• Resistance to Cell Death and Its Modulation in Cancer Stem Cells.

  2016cites this paper
• Reprogramming of Molecular Switching Events in UPR Driven ER Stress: Scope for Development of Anticancer Therapeutics.

  2016cites this paper
• Noncanonical SQSTM1/p62-Nrf2 pathway activation mediates proteasome inhibitor resistance in multiple myeloma cells via redox, metabolic and translational reprogramming

  2016influential citation
• Impaired coordination between signaling pathways is revealed in human colorectal cancer using single-cell mass cytometry of archival tissue blocks

  2016cites this paper
• Endoplasmic Reticulum Stress and the Hallmarks of Cancer.

  2016cites this paper
• Resistance of Nonmelanoma Skin Cancer to Nonsurgical Treatments. Part II: Photodynamic Therapy, Vismodegib, Cetuximab, Intralesional Methotrexate, and Radiotherapy.

  2016cites this paper
• Sorafenib, a multikinase inhibitor, induces formation of stress granules in hepatocarcinoma cells

  2015cites this paper
• UPR, autophagy, and mitochondria crosstalk underlies the ER stress response.

  2015cites this paper
• Drug Resistance of Endocardial Endothelial Cells is Related to Higher Endogenous ABCG2

  2015cites this paper
• Beyond the mammography debate: a moderate perspective.

  2015cites this paper
• On the role of 4-hydroxynonenal in health and disease.

  2015cites this paper